Submitted by Nicola-Swanborough on Thu, 26/10/2017 - 13:31
Our content manager, Nicola Swanborough, explains how our sodium valproate survey helped us raise awareness of risks associated with the drug in the media, parliament and with Government.
Submitted by Nicola-Swanborough on Thu, 19/10/2017 - 19:10
Although we could not see them as we watched today's sodium valproate debate via Parliament Live TV, the presence of three women -Janet Williams, Emma Murphy and Deborah Mann - as they sat in the public gallery, was very much felt in the House of Commons.
Submitted by Nicola-Swanborough on Thu, 19/10/2017 - 11:45
Epilepsy Society's chief executive, Clare Pelham, has welcomed a second letter from the Department of Health in response to her letter to health secretary Jeremy Hunt, calling for mandatory reviews for women and girls of childbearing age taking sodium valproate.
Submitted by carl-charlesworth on Wed, 27/09/2017 - 15:17
Epilepsy Society's chief executive Clare Pelham wins an honorary degree of doctor of the university from the Open University for her work around people with disabilities.
Submitted by carl-charlesworth on Mon, 23/01/2017 - 16:14
Epilepsy Society's Chief Executive Clare Pelham is encouraged that the health of patients is being put ahead of business after the Competition Appeal Tribunal refused to suspend the Competition Markets Authority's ruling that they had to reduce the price of phenytoin sodium capsules by today.
Submitted by helen-skipworth on Tue, 17/01/2017 - 16:23
Epilepsy Society's chief executive Clare Pelham has expressed frustration that pharmaceutical company Flynn Pharma has failed to reassure her of their long-term commitment to supplying the epilepsy drug, phenytoin sodium capsules.
Submitted by Nicola-Swanborough on Thu, 05/01/2017 - 12:27
Our chief executive, Clare Pelham and acting chairman of the board of trustees, Adrian Waddingham look at why it might be better to tackle 2017, one day at a time.
Submitted by Nicola-Swanborough on Tue, 13/12/2016 - 12:25
Epilepsy Society has paid tribute to legendary jockey Walter Swinburn who has died at the age of 55.
Submitted by Nicola-Swanborough on Fri, 09/12/2016 - 18:10
The UK-based pharmaceutical company Flynn Pharma Ltd has written to Epilepsy Society's chief executive Clare Pelham to reassure her that they do not foresee any disruption to supply or availability of the epilepsy drug phenytoin sodium.
Submitted by Nicola-Swanborough on Fri, 09/12/2016 - 10:03
A letter in today's Times (9 December 2016) from Epilepsy Society's chief executive Clare Pelham calls on drug company Pfizer to give people with epilepsy a hard and fast guarantee that it will continue to manufacture phenytoin sodium capsules.